PR Newswire MILAN, Oct. 9, 2024 MILAN, Oct. 9, 2024 /PRNewswire/ -- Daewoong Pharmaceutical (Co-CEOs Seongsoo Park and Chang-jae Lee) announced on the 9th that they will present their cutting-edge drug delivery technologies, including the ...
PR Newswire ST. LOUIS, Oct. 3, 2024 New Intensive Weight Loss Program for Mercy Patients ST. LOUIS, Oct. 3, 2024 /PRNewswire/ -- Mercy received a nearly $3 million funding award from the Patient-Centered Outcomes Research Institute ...
PR Newswire SALT LAKE CITY, Oct. 2, 2024 SALT LAKE CITY, Oct. 2, 2024 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral ...
PR Newswire CHARLOTTESVILLE, Va. and SAN FRANCISCO, Sept. 30, 2024 – Results from the placebo-controlled study in patients with obesity-related heart failure with preserved ejection fraction (HFpEF) were presented in a Late Breaking Clinical ...
PR Newswire CAMBRIDGE, Mass., Sept. 30, 2024 Data Revealed Favorable Safety, Tolerability and Dose-Linear Pharmacokinetics (PK) Top-Line Data Readout from the MAD Part 2 Expected in the First Quarter of 2025 Planned Phase 1 Part 3 ...
PR Newswire CAESAREA, Israel, Sept. 27, 2024 CAESAREA, Israel, Sept. 27, 2024 /PRNewswire/ -- Nitinotes, developers of EndoZip™, a fully automated endoscopic suturing system, proudly announces the publication of their pivotal study, ...
PR Newswire AMSTERDAM, Sept. 25, 2024 A pioneering study, presented today at the EADV Congress 2024, demonstrates the significant potential of semaglutide in treating hidradenitis suppurative (HS), a common and chronic skin condition, in ...
PR Newswire LEHI, Utah, Sept. 23, 2024 LEHI, Utah, Sept. 23, 2024 /PRNewswire/ -- Halia Therapeutics, Inc. (Halia), a clinical-stage biopharmaceutical company advancing novel therapies for inflammation-related diseases, today announced ...
PR Newswire HONG KONG, Sept. 17, 2024 - ASC30 is the first and only small molecule GLP-1 receptor (GLP-1R) agonist that can be dosed once-monthly subcutaneously and once-daily orally to treat obesity - ASC30 is two- to threefold more ...
PR Newswire TAMPA, Fla., Sept. 12, 2024 TAMPA, Fla., Sept. 12, 2024 /PRNewswire/ -- The Obesity Action Coalition (OAC) today responded to the Centers for Disease Control and Prevention's (CDC) newest data on obesity prevalence in the United ...
Soumya Swaminathan, former WHO Chief Scientist, highlights that the rise in abdominal obesity in India is largely due to unhealthy diets and a lack of physical activity, pointing to a significant public health concern ( ). ...
Essential need to preserve skeletal muscle mass when using GLP-1 receptor agonists for weight loss has been highlighted in the Lancet editorial. Although effective for obesity treatment, these medications raise concerns over the potential for ...
Expanding access to new and highly effective weight-loss medications could save over 40,000 deaths every year in the United States ( ). A recent study by the Yale School of Public Health and the University of Florida, explains the ...
New blood test has been developed that measures lipids to identify children at risk of obesity-related complications, including type 2 diabetes , liver disease , and heart disease , as per a study from King’s College London published in Nature ...
A BMJ investigation has uncovered a widespread lack of access to obesity care in England. Nearly half of the country's patients cannot see specialist weight loss teams, and...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers